ESTRO 35 Programme book

ELECTRONIC POSTERS

> Stereotactic radiotherapy for recurrent pancreatic adnocarcinoma at stump or abdominal lymph nodes H.H. Wang (China), H.H. Wang, M.B. Meng, Z.Q. Wu, Y.C. Song, H.Q. Zhuang, D. Qian, L.J. Zhao, Z.Y. Yuan > Concurrent high-dose (60-70 Gy) radiation and chemotherapy for esophageal cancer: long-term results T. Kondo (Japan), Y. Shibamoto, A. Hayashi, A. Miyakawa, T. Murai, T. Yanagi, C. Sugie, Y. Ogawa > Clinical significance of lymphocyte count before chemoradiotherapy in resected pancreatic cancer J. Heo (Republic of Korea), O.K. Noh, H.W. Lee, M. Chun, Y.T. Oh, J. Kim EP-1259 > Prognostic factors in hepatoma patients treated with radiotherapy for lymph node metastasis C.W. Wee (Republic of Korea), K. Kim, E.K. Chie, S.J. Yu, Y.J. Kim, J.H. Yoon EP-1260 > Impact of sarcopenia on adverse effects in trimodality therapy for esophageal carcinoma C. Panje (Switzerland), L. Höng, G. Henke, T. Ruhstaller, M. Guckenberger, V. Baracos, L. Plasswilm EP-1261 EP-1257 EP-1258 > Survival and symptom relief after salvage radio(chemo)therapy for recurrent esophageal cancer P.G. Kup, A. Gitt, H. Bühler, I.A. Adamietz, K. Fakhrian (Germany) > Survival and symptom relief after palliative radiotherapy for esophageal cancer P.G. Kup, J. Welsch, H. Bühler, H. Hermani, I.A. Adamietz, K. Fakhrian (Germany) > Patterns of recurrence in stage pT3N0M0 thoracic ESCC patients after two-field esophagectomy Y.X. Wang (China), L.L. Wang, Z.S. Li, M. He, Q. Yang, J. Li, Z. Qi, S.C. Zhu, X.Y. Qiao > Salvage chemoradiation for locoregional recurrences of esophageal cancer after curative treatment P.M. Jeene (The Netherlands), E. Versteijne, E.D. Geijsen, M.I. Van Berge Henegouwen, J.J.G.H.M. Bergmann, K. Muller, H.W.M. Van Laarhoven, M.C.C.M. Hulshof EP-1262 EP-1263 EP-1264 EP-1265

POSTERS AND ELECTRONIC POSTERS | PROGRAMME AND EXHIBITION GUIDE

237